# Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride

> **NCT00662337** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Consumer and Personal Products Worldwide** · enrollment: 36 (actual)

## Conditions studied

- Nasal Congestion

## Interventions

- **DRUG:** Diphenhydramine hydrochloride

## Key facts

- **NCT ID:** NCT00662337
- **Lead sponsor:** Johnson & Johnson Consumer and Personal Products Worldwide
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2011-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00662337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00662337, "Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00662337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*